Results from a new study in JAMA found that the Million Hearts Model, which paid participating health care organizations to assess and reduce patients’ CVD risk, decreased myocardial infarction and stroke rates for Medicare fee-for-service beneficiaries aged 40 to 79 years at high or medium risk for these events.

DEA will continue to allow providers to use telemedicine to prescribe certain controlled substances through the end of 2024.

A new study published in JAMA Network Open found that an intervention involving patient assessments by trained pharmacists in conjunction with primary care physicians led to better glycemic control among Hispanic patients with T2D.